Paper31548522
Collagen Autoantibodies and Their Relationship to CCP Antibodies and Rheumatoid Factor in the Progression of Early Rheumatoid Arthritis.
Whittingham SF and 2 others. Antibodies (Basel), 2017. Cited by 9 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Collagen Autoantibodies and Their Relationship to CCP Antibodies and Rheumatoid Factor in the Progression of Early Rheumatoid Arthritis. Papers, record 31548522. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31548522
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Collagen Autoantibodies and Their Relationship to CCP Antibodies and Rheumatoid Factor in the Progression of Early Rheumatoid Arthritis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References81
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10616002 | Antibodies to type II collagen and HLA disease susceptibility markers in rheumatoid arthritis. | Arthritis Rheum | 1999 | https://conductscience.org/library/papers/10616002 | PubMed |
| 2 | 10754334 | A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. | J Immunol | 2000 | https://conductscience.org/library/papers/10754334 | PubMed |
| 3 | 11385610 | Cartilage-specific autoimmunity in rheumatoid arthritis: characterization of a triple helical B cell epitope in the integrin-binding-domain of collagen type II. | Eur J Immunol | 2001 | https://conductscience.org/library/papers/11385610 | PubMed |
| 4 | 11431421 | Identification of conformation-dependent epitopes and V gene selection in the B cell response to type II collagen in the DA rat. | Int Immunol | 2001 | https://conductscience.org/library/papers/11431421 | PubMed |
| 5 | 11956298 | Arthritogenic monoclonal antibodies from K/BxN mice. | J Exp Med | 2002 | https://conductscience.org/library/papers/11956298 | PubMed |
| 6 | 12115216 | Criteria for early rheumatoid arthritis: from Bayes' law revisited to new thoughts on pathogenesis. | Arthritis Rheum | 2002 | https://conductscience.org/library/papers/12115216 | PubMed |
| 7 | 12355481 | Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. | Arthritis Rheum | 2002 | https://conductscience.org/library/papers/12355481 | PubMed |
| 8 | 125289 | Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor. | J Clin Invest | 1975 | https://conductscience.org/library/papers/125289 | PubMed |
| 9 | 131672 | The cyanogen bromide peptides of bovine soluble and insoluble collagens. I. Characterization of peptides from soluble type I collagen by sodium dodecylsulphate polyacrylamide gel electrophoresis. | Connect Tissue Res | 1976 | https://conductscience.org/library/papers/131672 | PubMed |
| 11 | 14011370 | Transient appearance of the rheumatoid factor in connection with prophylactic vaccinations. | Acta Pathol Microbiol Scand | 1962 | https://conductscience.org/library/papers/14011370 | PubMed |
| 12 | 14192518 | HEMOLYTIC COMPLEMENT IN SYNOVIAL FLUID. | J Clin Invest | 1964 | https://conductscience.org/library/papers/14192518 | PubMed |
| 13 | 1428342 | The diagnostic significance of anti-type II collagen antibody assay in rheumatoid arthritis. | Int Orthop | 1992 | https://conductscience.org/library/papers/1428342 | PubMed |
| 14 | 14558078 | Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. | Arthritis Rheum | 2003 | https://conductscience.org/library/papers/14558078 | PubMed |
| 15 | 14578183 | Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. | Am J Pathol | 2003 | https://conductscience.org/library/papers/14578183 | PubMed |
| 16 | 15283854 | An arthritogenic monoclonal antibody to type II collagen, CII-C1, impairs cartilage formation by cultured chondrocytes. | Immunol Cell Biol | 2004 | https://conductscience.org/library/papers/15283854 | PubMed |
| 17 | 15380047 | Antibodies against the CB10 fragment of type II collagen in rheumatoid arthritis. | Arthritis Res Ther | 2004 | https://conductscience.org/library/papers/15380047 | PubMed |
| 18 | 15529392 | The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. | Arthritis Rheum | 2004 | https://conductscience.org/library/papers/15529392 | PubMed |
| 19 | 15832289 | Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis. | Eur J Immunol | 2005 | https://conductscience.org/library/papers/15832289 | PubMed |
| 20 | 15843452 | Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. | Ann Rheum Dis | 2005 | https://conductscience.org/library/papers/15843452 | PubMed |
| 21 | 15934095 | Arthritogenic anti-type II collagen antibodies are pathogenic for cartilage-derived chondrocytes independent of inflammatory cells. | Arthritis Rheum | 2005 | https://conductscience.org/library/papers/15934095 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41197961 | Matrix metalloproteinase 13 (MMP-13) processing of type II collagen is altered by antibodies and citrullination found in the early stages of rheumatoid arthritis. | Matrix Biol | 2025 | https://conductscience.org/library/papers/41197961 | PubMed |
| 37373030 | Significance of Type II Collagen Posttranslational Modifications: From Autoantigenesis to Improved Diagnosis and Treatment of Rheumatoid Arthritis. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37373030 | PubMed |
| 36105231 | Tripterygium wilfordii glycosides ameliorates collagen-induced arthritis and aberrant lipid metabolism in rats. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36105231 | PubMed |
| 35686126 | Circular RNA circNUP214 Modulates the T Helper 17 Cell Response in Patients With Rheumatoid Arthritis. | Front Immunol | 2022 | https://conductscience.org/library/papers/35686126 | PubMed |
| 32874480 | Hyperbaric oxygen in animal model of rheumatoid arthritis: Analysis Of HIF-1α, ACPA and IL-17a. | Infect Dis Rep | 2020 | https://conductscience.org/library/papers/32874480 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31548522
GET https://conductscience.org/api/papers/v1/31548522/references?page=2